Skip to main content
Premium Trial:

Request an Annual Quote

Millipore Extends Cell Signaling Tools Deal with University of Dundee

NEW YORK (GenomeWeb News) – Millipore and the University of Dundee have signed a five-year extension of an exclusive license agreement to market cell signaling materials for research applications.
The collaboration began in 1995 between the university and Upstate Biotechnology, which is now part of Millipore. Research tools derived from the collaboration will be sold to researchers worldwide by Millipore, which already sells reagents derived from the collaboration as part of its KinaseProfiler and PhosphataseProfiler selectivity screening services.
As part of the extended license, Millipore will have access to new research products developed by researchers at the Medical Research Council Protein Phosphorylation Unit, which, in collaboration with the University of Dundee, has developed specific kinase and phosphatase methods and reagents for studying cell signaling.
Financial terms of the licensing pact were not disclosed.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.